Jackson Thornton Wealth Management’s Pfizer PFE Stock Holding History
Bought
Maintained
Sold
Other funds holding PFE
Jackson Thornton Wealth Management's PFE Position: Q2 2026 in Review
Jackson Thornton Wealth Management increased its Pfizer (PFE) stake by 8.8% in Q2 2026, buying an estimated $33.8K and bringing the position to 15,962 shares worth $384K. The position accounts for 0.03% of the portfolio, ranked #207.
Jackson Thornton Wealth Management first reported a position in PFE in Q2 2025 and has held it in 5 quarters since. The position peaked at $395K in Q1 2026. 2,827 funds tracked by Wall St. Rank hold PFE as of Q2 2026.
- Jackson Thornton Wealth Management held 15,962 shares of Pfizer worth $384K as of Q2 2026.
- Jackson Thornton Wealth Management bought 1,294 Pfizer shares in Q2 2026, an estimated $33.8K.
- Pfizer made up 0.03% of Jackson Thornton Wealth Management's portfolio in Q2 2026, its #207 holding.
- Jackson Thornton Wealth Management first reported a position in Pfizer in Q2 2025 and has held it in 5 quarters since.
- Jackson Thornton Wealth Management's Pfizer position peaked at $395K in Q1 2026.
- 2,827 funds tracked by Wall St. Rank held Pfizer as of Q2 2026.
Based on Jackson Thornton Wealth Management's 13F filing for Q2 2026, filed 6 Aug 2026.